Illumina has announced that deCODE genetics, which operates the services facility offering Illumina single-nucleotide polymorphisms (SNP) genotyping services, has received Illumina Certified Service Provider (CSPro) certification for Infinium® Genotyping.
decode has partnered with Illumina to provide high-value content for the Infinium Genotyping BeadChip, delivering industry-leading results for genotyping service customers.
“We chose Illumina because their data quality is the best in the industry, and through our genotyping services we can in turn offer this level of quality to our customers around the world. Our Disease Miner™ informatics suite further provides our customers with a user-friendly means of performing their own data management and statistical analyses,” said Jeff Gulcher, deCODE’s Chief Scientific Officer.
Gulcher said, “Receiving CSPro certification underscores deCODE’s commitment to providing the best and most comprehensive genotyping and analytical solutions, speeding the discovery process for our customers.”
“deCODE is the largest laboratory to offer Infinium Genotyping services, serving a growing list of customers in North America, Europe, and Asia. They are also the first company outside of North America to achieve Illumina CSPro certification for Infinium Genotyping,” said Karen Possemato, Illumina's Director of Corporate Marketing.
“By contributing its unrivalled expertise in human genetics, deCODE has helped to ensure that next generation Infinium Genotyping products lead the industry in quality and content,” Possemato continued.